Jodie Pope Morrison
CIK 1618247 · CEO · last filed 2026-03-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.85M
Companies
7
Total Filings
30
Lifetime Open-Market Net
-$533.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QTTB | CEO | 221,104 | $12.64 | $2.79M | -$141.4K | 6 | 2026-03-20 |
| Verve Therapeutics, Inc. (VERV) Delisted | Director | — | $11.13 | — | $0 | 3 | 2025-07-28 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | — | $2.11 | — | $0 | 6 | 2022-06-17 |
| AKBA | Director | 58,619 | $0.92 | $54.2K | $0 | 2 | 2019-06-10 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Interim CEO | 0 | — | — | $0 | 5 | 2018-12-13 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | — | — | — | $0 | 1 | 2017-07-05 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | President and CEO | 37,566 | — | — | -$392.4K | 7 | 2016-01-08 |
Recent Filings · Page 2 of 3
30 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-17 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-21 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-10 | AKBA | Grant (A) | +13,700 | $0 | EDGAR |
| 2018-12-13 | AKBA | Grant (A) | +44,919 | $0 | EDGAR |
| 2018-12-13 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Disp (D) | −120,000 | $0 | EDGAR |
| 2018-07-12 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2018-06-25 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-14 | KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2017-07-27 | Rein Therapeutics, Inc. (ALRN) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.